A monoclonal-antibody drug created by Vir Biotechnology Inc. and GlaxoSmithKline PLC is reduced hospitalizations or death from Covid-19 by 85%.
Eventually, we are going to beat COVID-19 and possible get rid of it.
Due to the outstanding results of this drug, its creators are going to request the U.S. and other countries to authorize its use.
If allowed, this would be the 4th antibody-drug in the U.S. that helps fight COVID-19. This just shows you that we are working towards beating this virus.